Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
 
Join | Sign in
Home>Resources>Webcasts

  Webcasts

Scientific News
Epigenomics of Alzheimer’s Disease Progression
Study of epigenomic modifications reveals immune basis of Alzheimer's disease.
Single-Cell, 42-plexed Protein Analysis Achieved with a New Microchip Technology
A novel microdevice capable of detecting 42 unique immune effector proteins has been developed.
New Therapeutic Strategy Discovered for Ovarian Cancer
New therapeutic target could lead to the first effected targeted therapy for aggressive forms of ovarian cancer.
MAGE Genes Provide Insight into Optimizing Chemotherapy
UT Southwestern Medical Center scientists have identified a new biomarker that could help identify patients who are more likely to respond to certain chemotherapies.
Dynamic Profiling Of The Protein Life Cycle In Response To Pathogens
A quantitative genomic model is used to explain the abundance of proteins in cells based on mRNA expression, translation, and degradation.
New Biomarkers To Spot Pancreatic Cancer Early
A combination of two biomarkers can identify pre-clinical pancreatic cancer.
Two Genetic Mutations That Interact To Lower Heart Attack Risk Identified
About 20 percent of the population has this protective genetic combination.
Epigenetic Signatures that Differentiate Triple-Negative Breast Cancers
Australian researchers have identified epigenetic ‘signatures’ that could help clinicians tell the difference between highly aggressive and more benign forms of triple-negative breast cancer.
A ‘STAR’ is Born: Engineers Devise Genetic 'On' Switch
A new “on” switch to control gene expression has been developed by Cornell scientists.
New Techniques Reveal “Extreme” Gene Copy Range
New findings give scientists the first precise way to study places in the genome where the number of copies of a sequence varies widely from person to person.

Application of Profiling the Antibody Repertoire for Discovery of Cancer Biomarkers.
Delores Cahill, University College Dublin, Professor, speaking at Cancer Proteomics 2010.

13CO2 a Biomarker in Breath for Individualized Cancer Therapy
Anil Modak, Cambridge Isotope Laboratory, Associate Director, speaking at Cancer Proteomics 2010.

The Foundation of the NIH (FNIH) Biomarkers Consortium Builds Consensus Through Public Private Partnerships
Maria Vassileva, Scientific Program Manager, Foundation for the National Institutes of Health, speaking at European Biomarkers Summit 2009

Industry Snapshot: Cancer Personalized Medicine Market Landscape
Enal Razvi, Biotechnology Analyst, Select Biosciences, speaking at European Biomarkers Summit 2009

Genetic Polymorphisms Associated to Adverse Reactions to 5-FU or Capecitabine in Colorectal Cancer Patients
Luis Lopez-Fernandez, Lab Director, Hospital General Universitario Gregorio Marañon, speaking at European Biomarkers Summit 2009

Biomarker Qualification: Europe is ready, are you?
Patricia Hurley, Division Head, ERA Consulting, speaking at European Biomarkers Summit 2009

Lessons Learned From HTS: The Short and Long Journey to Probe Discovery
Hakim Djaballah, Director, Memorial Sloan Kettering Cancer Center, speaking at Probe Discovery 2009

Lead-discovery and Probe Development in Smaller Academic-based HTS Labs
Andy Mesecar, Professor, University of Illinois, speaking at Probe Discovery 2009

Exploratory Pharmacogenetic Analysis of Efalizumab Responders
Emmanuel Monnet, Head of Biomarker, Merck Serono, speaking at Molecular Diagnostics World Congress 2009

<< 5 6 7 8 9 10 11 >>
Showing Results 71 - 80 of 133
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters